Using a three-dimensional in vitro tumoral model we showed that the expression of lncMat2B, a lncRNA expressed in the hypoxic regions of multicellular tumor spheroids (MCTS), is increased in the CD44+/CD24- breast cancer cell subpopulation [70]. The gene discussed is CD24; the disease is breast cancer.